Crisaborole Topical Ointment, 2%, a novel nonsteroidal, anti-inflammatory, topical, phosphodiesterase 4 inhibitor, reduced pruritus and signs of atopic dermatitis in 2 phase 3 studies in children and adults with mild-to-moderate atopic dermatitis

被引：0
|
作者：
Zane, Lee Thomas [1 ]
Hebert, Adelaide A. [2 ]
Eichenfield, Lawrence F. [3 ,4 ]
Lebwohl, Mark G. [5 ]
Paller, Amy S. [6 ]
Simpson, Eric L. [7 ]
Tom, Wynnis L. [3 ,4 ]
Hughes, Matty H. [1 ]
机构：
[1] Anacor Pharmaceut Inc, Palo Alto, CA USA
[2] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[3] Rady Childrens Hosp, San Diego, CA USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
[7] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF IMMUNOLOGY | 2016年 / 196卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups
    Callender, Valerie D.
    Alexis, Andrew F.
    Gold, Linda F. Stein
    Lebwohl, Mark G.
    Paller, Amy S.
    Desai, Seemal R.
    Tan, Huaming
    Ports, William C.
    Zielinski, Michael A.
    Tallman, Anna M.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (05) : 711 - 723
  • [32] CRISABOROLE OINTMENT PROVIDES EARLY RELIEF OF PRURITUS IN TWO PHASE 3 CLINICAL TRIALS IN PATIENTS WITH MILD OR MODERATE ATOPIC DERMATITIS
    Guttman-Yasky, Emma
    Yosipovitch, Gil
    Murrell, Dedee
    Ha-Nifin, Jon
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 1015 - 1016
  • [33] Crisaborole ointment provides early relief of pruritus in two phase 3 clinical trials in patients with mild or moderate atopic dermatitis
    Guttman-Yassky, E.
    Yosipovitch, G.
    Murrell, D.
    Hanifin, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S194 - S194
  • [34] Crisaborole Topical Ointment, 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept Study
    Murrell, Dedee F.
    Gebauer, Kurt
    Spelman, Lynda
    Zane, Lee T.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (10) : 1108 - 1112
  • [35] Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years
    Luger, Thomas A.
    Hebert, Adelaide A.
    Zaenglein, Andrea L.
    Silverberg, Jonathan, I
    Tan, Huaming
    Ports, William C.
    Zielinski, Michael A.
    PEDIATRIC DRUGS, 2022, 24 (02) : 175 - 183
  • [36] Safety and efficacy of AN2728 topical ointment, 2% and 0.5%, in a phase 2 dose-ranging study of adolescents with mild-to-moderate atopic dermatitis
    Stein-Gold, L.
    Spelman, L.
    Spellman, M.
    Hughes, M.
    Zane, L. T.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 : 16 - 16
  • [37] Safety and efficacy of AN2728 topical ointment, 2% and 0.5%, in a phase 2 dose-ranging study of adolescents with mild-to-moderate atopic dermatitis
    Stein-Gold, L.
    Spelman, L.
    Spellman, M. C.
    Hughes, M.
    Zane, L. T.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (06) : E15 - E16
  • [38] Safety and efficacy of AN2728 topical ointment, 2% and 0.5%, in a phase 2 dose-ranging study of adolescents with mild-to-moderate atopic dermatitis
    Stein-Gold, L.
    Spelman, L.
    Spellman, M.
    Hughes, M.
    Zane, L.
    EXPERIMENTAL DERMATOLOGY, 2014, 23 : 6 - 6
  • [39] Safety and Efficacy of AN2728 Topical Ointment, 2% and 0.5%, in a Phase 2 Dose-Ranging Study of Adolescents with Mild-To-Moderate Atopic Dermatitis
    Stein-Gold, L.
    Spelman, L.
    Spellman, M. C.
    Hughes, M.
    Zane, L. T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 14 - 14
  • [40] Early improvement in pruritus and reduction in clinical signs in a phase 2a mechanism of action study of crisaborole in mild to moderate atopic dermatitis
    Bissonnette, R.
    Ports, W. C.
    Zang, C.
    Vranic, I.
    Werth, J. L.
    Purohit, V. S.
    Zielinski, M. A.
    Vlahos, B.
    Saint-Cyr-Proulx, E.
    Estrada, Y. D.
    Pavel, A. B.
    Guttman-Yassky, E.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 49 - 50
12345